Ashrafi Hafez Asghar, Baharlou Rasoul, Mousavi Nasab Seyed Dawood, Ahmadi Vasmehjani Abbas, Shayestehpour Mohammad, Joharinia Negar, Ahmadi Nayeb Ali
Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.
Department of Microbiology, Jahrom University of Medical Sciences, Jahrom, IR Iran.
Hepat Mon. 2014 May 11;14(5):e16391. doi: 10.5812/hepatmon.16391. eCollection 2014 May.
The Hepatitis C Virus (HCV) is considered essentially hepatotropic, yet the virus compartments have also been found in important extra hepatic sites. Detection of HCV RNA in extra hepatic reservoirs such as peripheral blood mononuclear cells (PBMCs) is important for determining disease progression and treatment effectiveness.
The present study aimed to determine different HCV genotypes in patients' plasma and PBMC specimens, in Jahrom city of Iran.
Blood samples of 137 patients with established HCV were collected at the Honari clinic. These patients were anti-HCV and plasma HCV RNA positive. After plasma RNA extraction and obtaining a pellet of approximately 3-5 × 10(6) PBMCs, Real-time PCR was performed, using specific-genotype primers. Finally, data analysis was done by the Statistical Package for Social Sciences (SPSS) software.
Subtype 3 was the most common genotype in plasma (57.7%) and PBMCs (51.1%). Subtype 1a was detected in 36.5% and 30.7% of plasma samples and PBMCs, respectively whereas subtype 4 was not detected in any of the cases. There was a genotype difference between plasma and PBMCs of 12.4% of patients. In four patients no genotype was detected in their plasma but genotype 3 was detected in the PBMCs.
It is suggested that determination of the target genotype by plasma subtyping for choosing the proper antiviral therapy is essential but may result in therapy failure. HCV genotyping in PBMC samples, along with plasma specimens, might be more beneficial. Therefore determining the HCV genotype in PBMCs, before beginning the therapy is useful due to the possibility of occult infection detection.
丙型肝炎病毒(HCV)本质上被认为是嗜肝性的,但也已在重要的肝外部位发现病毒存在。在肝外储存库如外周血单核细胞(PBMCs)中检测HCV RNA对于确定疾病进展和治疗效果很重要。
本研究旨在确定伊朗贾赫罗姆市患者血浆和PBMC样本中的不同HCV基因型。
在霍纳里诊所采集了137例确诊为HCV的患者的血样。这些患者抗-HCV和血浆HCV RNA均呈阳性。在提取血浆RNA并获得约3 - 5×10⁶个PBMC的沉淀后,使用特定基因型引物进行实时PCR。最后,通过社会科学统计软件包(SPSS)进行数据分析。
3型是血浆(57.7%)和PBMCs(51.1%)中最常见的基因型。1a型分别在36.5%的血浆样本和30.7%的PBMCs中被检测到,而在任何病例中均未检测到4型。12.4%的患者血浆和PBMCs之间存在基因型差异。在4例患者中,血浆中未检测到基因型,但在PBMCs中检测到3型。
建议通过血浆亚型确定目标基因型以选择合适的抗病毒治疗至关重要,但可能导致治疗失败。PBMC样本与血浆样本一起进行HCV基因分型可能更有益。因此,由于有可能检测到隐匿性感染,在开始治疗前确定PBMCs中的HCV基因型是有用的。